{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:45:34Z","timestamp":1791081934297,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52303369"],"award-info":[{"award-number":["52303369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["23ZR1405400"],"award-info":[{"award-number":["23ZR1405400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400100"],"award-info":[{"award-number":["2022YFC3400100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114569","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:42:37Z","timestamp":1766389357000},"page":"114569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hepatocyte-specific partial cellular reprogramming via selective OSK mRNA lipid nanoparticle attenuates liver fibrosis"],"prefix":"10.1016","volume":"390","author":[{"given":"Chenchen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuerong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114569_bb0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2025.114569_bb0010","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.stem.2023.10.008","article-title":"VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis","volume":"30","author":"Rizvi","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2025.114569_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103109","article-title":"Advancing in vivo reprogramming with synthetic biology","volume":"87","author":"Islam","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jdb12010001","article-title":"Cell reprogramming and differentiation utilizing messenger RNA for regenerative medicine","volume":"12","author":"Inagaki","year":"2023","journal-title":"J. Dev. Biol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114569_bb0030","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.5c05367","article-title":"Breaking endosomal barriers: thiol-mediated uptake lipid nanoparticles for efficient mRNA vaccine delivery","author":"Lian","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114569_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115026","article-title":"Gene editing therapeutics based on mRNA delivery","volume":"200","author":"Popovitz","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114569_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113837","article-title":"Unlock the sustained therapeutic efficacy of mRNA","volume":"383","author":"Cao","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114569_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2025.114569_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114569_bb0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and cilinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114569_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114569_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bea.2024.100118","article-title":"Understanding fibrosis: mechanisms, clinical implications, current therapies, and prospects for future interventions","volume":"7","author":"Ku","year":"2024","journal-title":"Biomed. Eng. Adv."},{"key":"10.1016\/j.jconrel.2025.114569_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41419-019-1311-0","article-title":"SVIP alleviates CCl(4)-induced liver fibrosis via activating autophagy and protecting hepatocytes","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.114569_bb0080","article-title":"Vicious cycle-breaking lipid nanoparticles remodeling multicellular crosstalk to reverse liver fibrosis","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114569_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202405678","article-title":"OPN-mediated crosstalk between hepatocyte E4BP4 and hepatic stellate cells promotes MASH-associated liver fibrosis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114569_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410416","article-title":"Targeting fibrosis: from molecular mechanisms to advanced therapies","volume":"12","author":"Di","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114569_bb0095","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.3390\/ijms24119671","article-title":"Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities","volume":"24","author":"Pei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114569_bb0100","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","article-title":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4(\u2212\/\u2212) mouse model of PFIC3","volume":"74","author":"Wei","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0105","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1038\/s41467-024-49332-8","article-title":"Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice","volume":"15","author":"Smith","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114569_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110730","article-title":"In vivo partial cellular reprogramming enhances liver plasticity and regeneration","volume":"39","author":"Hishida","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114569_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg1777","article-title":"Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging","volume":"16","author":"Sahu","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114569_bb0120","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/s41467-021-23353-z","article-title":"In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114569_bb0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-020-2975-4","article-title":"Reprogramming to recover youthful epigenetic information and restore vision","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114569_bb0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2014.12.016","article-title":"Reduced expression of MYC increases longevity and enhances healthspan","volume":"160","author":"Hofmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114569_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.celrep.2018.03.057","article-title":"MYC releases early reprogrammed human cells from proliferation pause via retinoblastoma protein inhibition","volume":"23","author":"Rand","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114569_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115879","article-title":"Comparative analysis of mouse strains for in vivo induction of reprogramming factors","volume":"44","author":"Pic\u00f3","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114569_bb0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114569_bb0150","doi-asserted-by":"crossref","first-page":"13582","DOI":"10.1002\/anie.201809056","article-title":"Customizable lipid nanoparticle materials for the delivery of siRNAs and mRNAs","volume":"57","author":"Fenton","year":"2018","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114569_bb0155","article-title":"A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery","volume":"62","author":"He","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114569_bb0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/sb300023h","article-title":"A combinatorial library of unsaturated lipidoids for efficient intracellular gene delivery","volume":"1","author":"Wang","year":"2012","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0165","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114569_bb0170","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114569_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","article-title":"Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery","volume":"20","author":"Xue","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114569_bb0190","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0200","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1083\/jcb.201903090","article-title":"The cell biology of the hepatocyte: a membrane trafficking machine","volume":"218","author":"Schulze","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2025.114569_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1444198","article-title":"Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy","volume":"12","author":"Tian","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13287-022-03041-5","article-title":"Stem cells for treatment of liver fibrosis\/cirrhosis: clinical progress and therapeutic potential","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jconrel.2025.114569_bb0225","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1038\/s41467-024-50752-9","article-title":"Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114569_bb0230","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114569_bb0235","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41467-021-20903-3","article-title":"Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA","volume":"12","author":"Rizvi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114569_bb0240","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:20:05Z","timestamp":1781702405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S0168365925011836"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114569","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte-specific partial cellular reprogramming via selective OSK mRNA lipid nanoparticle attenuates liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114569"}}